alfimeprase: Clinical Trials

3 trials of alfimeprase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1

Follow alfimeprase: new trials by email Literature Review of alfimeprase trials Research Report on alfimeprase

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
alfimeprase - Acute Ischemic Stroke
Phase 2TerminatedARCA Biopharma, Inc.72007-06-012008-04-24
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
Alfimeprase - Arterial Occlusive Diseases, Peripheral Vascular Diseases
Phase 2CompletedARCA Biopharma, Inc.1002003-06-012009-12-17
Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices
Alfimeprase - Catheters, Indwelling
Phase 2CompletedARCA Biopharma, Inc.1152010-02-03

Conditions studied

Thrombosis (3)  ·  Arterial Occlusive Diseases (1)  ·  Ischemic Stroke (1)  ·  Peripheral Vascular Diseases (1)  ·  Stroke (1)

Sponsors

ARCA Biopharma, Inc. (3)

Countries

United States (3)  ·  Canada (1)

Top investigators

Susan M Begelman, MD (1)